Gender and Geographical Spreading of Cutaneous Leishmaniasis Infection in Southern Iraq

Authors

  • Abbas Ghafil Abbas Departement of Anatomy, College of Medicine University of Qadisiyah

DOI:

https://doi.org/10.51699/cajmns.v7i1.3103

Keywords:

leishmaniosis, geographic distribution, gender, cutaneous leishmaniasis

Abstract

Leishmaniosis is an endemic disease that occurs in over 88 countries and endangers an estimated 350 million people worldwide. One case per year, and more than 90% of issues are detected in Algeria, Afghanistan, Iran, Iraq, Syria, Saudi Arabia, Peru and Brazil. The perspectives that this study analyzes are the geographic distribution of infection rates of leishmaniosis and the gender differences and determinants of prevalence for building an epidemiological profile of leishmaniosis. Microscopic parasite detection, direct aspiration swabs are usually collected 1139 infected men and women in age group (10-55) years as of the provinces of Dhi Qar, Maysan, Muthanna, Najaf and Basra as of patients infected with leishmaniasis, often accompanied by staining; Amastigotes are typically round in form and 2–4 μm in diameter. Stain techniques help improve cell clarity, with Giemsa and Leishman stains most commonly used for this purpose. Out of 1,139 samples, 720 patients (61.63%) were infected. Infections were highest in Dhi Qar (335 women, 367 men), followed by Maysan (190), Najaf (110), Muthanna (100), and Basra (37). Males were more affected than females across all governorates. The present study, which examines high infection rates in regions such as Thi-Qar that are influenced by environmental conditions, highlights the need for targeted health interventions and improved environmental management to effectively control the disease.

References

World Health Organization (WHO), “Leishmaniasis,” 2021. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis

A. Asilian, A. Sadeghinia, G. Faghihi, and A. Momeni, “Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime®) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime®) alone for the treatment of cutaneous leishmaniasis,” *International Journal of Dermatology*, vol. 43, no. 4, pp. 281–283, 2004.

A. A. Abdul-Hussein, A. A. Yousif, O. T. Abed, and A. A. Jabbar, “Cutaneous leishmaniasis: A clinicoepidemiological study in Al Muthanna Governorate, Iraq,” Dept. of Medicine (Dermatology), College of Medicine, Muthanna University, Iraq, 2023.

J. Alvar, I. D. Vélez, C. Bern, *et al*., “Leishmaniasis worldwide and global estimates of its incidence,” *PLoS ONE*, vol. 7, no. 5, e35671, 2012.

S. Burza, S. L. Croft, and M. Boelaert, “Leishmaniasis,” *The Lancet*, vol. 392, no. 10151, pp. 951–970, 2018, doi: 10.1016/S0140-6736(18)31204-2.

World Health Organization (WHO), *Global Health Observatory Data Repository: Status of Endemicity of Cutaneous Leishmaniasis by Country*, 2013.

J. L. N. Barratt, J. Harkness, D. Marriott, J. T. Ellis, and D. Stark, “Importance of nonenteric protozoan infections in immunocompromised people,” *Clinical Microbiology Reviews*, vol. 23, no. 4, pp. 795–836, 2010.

World Health Organization (WHO), “Annex 3: Burden of disease in DALYs by cause, sex, and mortality stratum in WHO regions—Estimates for 2001,” 2002.

P. Desjeux, “Leishmaniasis: Public health aspects and control,” *Clinical Dermatology*, vol. 14, no. 5, pp. 417–423, 1996.

M. H. Flaih, F. A. Al-Abady, and K. R. Hussein, “Phylogenetic analysis of kinetoplast DNA (kDNA) of *Leishmania tropica* in Thi-Qar Province, Iraq,” *Comparative Immunology, Microbiology and Infectious Diseases*, vol. 78, Art. no. 101696, 2021.

M. M. H. Z. Abu Aldwanij, “Epidemiological aspects of cutaneous leishmaniasis in Maysan Governorate, Iraq,” *Maysan Journal of Academic*, no. 33, 2018.

H. S. J. Al-Ward, “Leishmania parasites and leishmaniasis: A historical and contemporary reference perspective,” *Journal of Basic Education College*, vol. 42, no. 14, 2018.

A. K. Jassim, R. Maktoof, H. Ali, B. Budosan, and K. Campbell, “Visceral leishmaniasis control in Thi-Qar Governorate, Iraq,” *Eastern Mediterranean Health Journal*, vol. 12, suppl. 2, 2003.

A. M. J. Al-Mousawy, “Molecular and immunological study of cutaneous leishmaniasis in the middle and southern provinces of Iraq,” Ph.D. dissertation, University of Kerbala, 2015.

F. A. Manshad and N. A. A. Abd Al-Kazim, “Epidemiological study on cutaneous leishmaniasis in infected persons in Thi-Qar Governorate,” *Journal of Thi-Qar University*, vol. 6, no. 1, 2016.

F. Bailey, K. Mondragon-Shem, P. Hotez, *et al*., “A new perspective on cutaneous leishmaniasis: Implications for global prevalence and burden of disease estimates,” *PLoS Neglected Tropical Diseases*, vol. 11, no. 8, e0005739, 2017.

H. W. Murray, J. D. Berman, C. R. Davies, and N. G. Saravia, “Advances in leishmaniasis,” *The Lancet*, vol. 366, no. 9496, pp. 1561–1577, 2005.

Communicable Disease Control Center, *Health Information for International Travel (The Yellow Book)*, 2016.

Leishmaniasis Control Program, *Annual Country Report: World Endemicity of Cutaneous Leishmaniasis*, 2016.

World Health Organization (WHO), *Communicable Disease Toolkit: Iraq*, 2008.

A. K. Kone, D. S. Niare, A. M. Thera, *et al*., “Epidemiology of the outbreak, vectors, and reservoirs of cutaneous leishmaniasis in Mali: A systematic review and meta-analysis,” *Asian Pacific Journal of Tropical Disease*, vol. 9, pp. 985–990, 2016.

A. Khosravi, I. Sharifi, and E. Dortaj, “The present status of cutaneous leishmaniasis in a recently emerged focus in Southwest Kerman Province, Iran,” *Iranian Journal of Public Health*, vol. 42, pp. 182–187, 2013.

E. Lesho, G. Wortman, R. Neafie, and N. Aronson, “Non-healing skin lesion in a sailor and journalist returning from Iraq,” *Cleveland Clinic Journal of Medicine*, vol. 72, no. 2, pp. 93–106, 2005.

S. Odiwuor, A. Muia, C. Magiri, *et al*., “Identification of *Leishmania tropica* from micro-foci of cutaneous leishmaniasis in the Kenyan Rift Valley,” *Pathogens and Global Health*, vol. 106, no. 3, pp. 159–165, 2012.

I. Müller, P. Kropf, R. J. Etges, J. A. Louis, and H. Himmelrich, “The immunology of *Leishmania* infection,” *Nature Reviews Immunology*, vol. 2, no. 12, pp. 941–952, 2000.

World Health Organization (WHO), “Leishmaniasis,” 2023.

R. Pour, I. Sharifi, and B. Kazemi, “Identification of nonresponsive isolates to Glucantime in patients with cutaneous leishmaniasis in Bam,” *Journal of Kerman University of Medical Sciences*, vol. 18, pp. 123–133, 2011.

Downloads

Published

2026-02-04

How to Cite

Abbas, A. G. . (2026). Gender and Geographical Spreading of Cutaneous Leishmaniasis Infection in Southern Iraq. Central Asian Journal of Medical and Natural Science, 7(1), 714–719. https://doi.org/10.51699/cajmns.v7i1.3103

Issue

Section

Articles